Sandbox: table diagnosis myxoa: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
The table below summarizes the findings that differentiate [[Cardiac Myxoma]] from other conditions that cause [[Emboli]] and [[hemorrhage]]:


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
Line 11: Line 10:
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Two- or three-dimensional echocardiography
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Two- or three-dimensional echocardiography
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Echocardiography is usually the initial modality used for identification and evaluation of cardiac myxomas.
*Echocardiography is usually the initial modality used for identification and evaluation of cardiac myxomas.
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Hyperechogenic lesions with a well-defined stalk
*Hyperechogenic lesions with a well-defined stalk
*Protrude into the ventricles is common.
*Protrusion into the ventricles is a common finding
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Real-time imaging  
*Real-time imaging  
Line 30: Line 28:
*'''T1''' : Low to intermediate signal, but areas of hemorrhage may be high.
*'''T1''' : Low to intermediate signal, but areas of hemorrhage may be high.
*'''T1 C+ (Gd)''': shows enhancement (important discriminator from a thrombus) demonstrates uniform heterogeneous enhancement.
*'''T1 C+ (Gd)''': shows enhancement (important discriminator from a thrombus) demonstrates uniform heterogeneous enhancement.
| style="padding: 5px 5px; background: #F5F5F5;" align=center| MRI allows imaging in multiple planes and can provide some functional information such as flow direction and flow velocity in large vessels
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Cannot show calcification *High susceptibility to motion artifact.
* MRI allows imaging in multiple planes
* Provides some functional information such as, flow direction and flow velocity in large vessels
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Cannot show calcification
*High susceptibility to motion artifact.
*Dependent on regular electrocardiographic rhythms and cardiac gating.
*Dependent on regular electrocardiographic rhythms and cardiac gating.
|-
|-
Line 41: Line 42:
*The attenuation is usually lower than that of myocardium
*The attenuation is usually lower than that of myocardium
*Calcification is common
*Calcification is common
| style="padding: 5px 5px; background: #F5F5F5;" align=center|CT provides better soft-tissue contrast
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|There is no real-time true imaging with CT and imaging planes are limited to those allowed by angulation of the gantry. There is no evaluation of small moving structures, such as the cardiac valves.
*CT provides better soft-tissue contrast
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*There is no real-time true imaging with CT and imaging planes are limited to those allowed by angulation of the gantry.
*There is no evaluation of small moving structures, such as the cardiac valves.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Angiography
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Angiography
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries
| style="padding: 5px 5px; background: #F5F5F5;" align=center|The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of tortuous vessels that correspond to tumor vasculature
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of tortuous vessels that correspond to tumor vasculature
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma
*Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma
Line 55: Line 60:
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Chest x-ray
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Chest x-ray
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Chest x-ray has no particular findings associated with cardiac myxoma
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Chest x-ray has no particular findings associated with cardiac myxoma
| style="padding: 5px 5px; background: #F5F5F5;" align=center|Results can be normal
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Results can be normal
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Low cost
*Low cost

Revision as of 19:12, 25 November 2015

Imaging Technique Features Description Advantages Limitations
Two- or three-dimensional echocardiography Echocardiography is usually the initial modality used for identification and evaluation of cardiac myxomas.
  • Hyperechogenic lesions with a well-defined stalk
  • Protrusion into the ventricles is a common finding
  • Real-time imaging
  • Tumor mobility and distensibility
  • Limited views of the mediastinum and cannot be used to evaluate extracardiac manifestations of disease.[1]
  • TEE is an invasive imaging technique.
  • TT is limited by the imaging window, which can vary with the patient and operator experience.
MRI Evaluation of cardiac masses and is of greatest value when echocardiographic findings are suboptimal or when the lesion has an atypical location or appearance.
  • Cardiac myxomas appear spherical or ovoid with lobular contours, irregular in shape.
  • T1 : Low to intermediate signal, but areas of hemorrhage may be high.
  • T1 C+ (Gd): shows enhancement (important discriminator from a thrombus) demonstrates uniform heterogeneous enhancement.
  • MRI allows imaging in multiple planes
  • Provides some functional information such as, flow direction and flow velocity in large vessels
  • Cannot show calcification
  • High susceptibility to motion artifact.
  • Dependent on regular electrocardiographic rhythms and cardiac gating.
CT CT can be used to accurately image the heart and surrounding mediastinum
  • Intracardiac heterogeneously low attenuating mass
  • The attenuation is usually lower than that of myocardium
  • Calcification is common
  • CT provides better soft-tissue contrast
  • There is no real-time true imaging with CT and imaging planes are limited to those allowed by angulation of the gantry.
  • There is no evaluation of small moving structures, such as the cardiac valves.
Angiography Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries
  • The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of tortuous vessels that correspond to tumor vasculature
  • Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma
  • Helpful for surgical evaluation
  • Invasive imaging technique
Chest x-ray Chest x-ray has no particular findings associated with cardiac myxoma
  • Results can be normal
  • Low cost
  • May be helpful, if calcifications present
  • Does not provide a diagnosis
  1. Reeder GS, Khandheria BK, Seward JB, Tajik AJ (1991). "Transesophageal echocardiography and cardiac masses". Mayo Clin. Proc. 66 (11): 1101–9. PMID 1943240.